Flaherty Keith T.
Director at Loxo Oncology, Inc.
- Sold, on record
- $11.4M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Jun 7, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Loxo Oncology, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Loxo Oncology, Inc.Plan not statedAug 11, 2016 2016
Sold 15,000 shares at $26.00 ($390k)
Flaherty Keith T., Director
Sold 19.9% of holdings ($2M position)60,482 shares leftFirst sale on recordFiling
- 2 Form 4 sale Loxo Oncology, Inc.Plan not statedSep 7, 2016 +27 days
Sold 14,500 shares at $30.00 ($435k)
Flaherty Keith T., Director
Sold 24% of holdings ($1.8M position)45,982 shares leftFiling
- 3 Form 4 sale Loxo Oncology, Inc.Plan not statedDec 19, 2016 +103 days
Sold 7,250 shares at $30.23 ($219k)
Flaherty Keith T., Director
Sold 15.8% of holdings ($1.4M position)38,732 shares leftFiling
- 4 Form 4 sale Loxo Oncology, Inc.Plan not statedFeb 21, 2017 +64 days
Sold 7,250 shares at $41.45 ($301k)
Flaherty Keith T., Director
Sold 18.7% of holdings ($1.6M position)31,482 shares left0.5x usual sizeFiling
- 5 Form 4 sale Loxo Oncology, Inc.Plan not statedMay 22, 2017 +90 days
Sold 7,250 shares at $45.09 ($327k)
Flaherty Keith T., Director
Sold 23% of holdings ($1.4M position)24,232 shares left0.7x usual sizeFiling
- 6 Form 4 sale Loxo Oncology, Inc.UnusualAug 21, 2017 +91 days
Sold 7,250 shares at $72.26 ($524k)
Flaherty Keith T., Director
Sold 29.9% of holdings ($1.8M position)16,982 shares left1x usual sizeFiling
- 7 Form 4 sale Loxo Oncology, Inc.UnusualNov 20, 2017 +91 days
Sold 7,250 shares at $75.99 ($551k)
Flaherty Keith T., Director
Sold 42.7% of holdings ($1.3M position)9,732 shares left1x usual sizeFiling
- 8 Form 4 sale Loxo Oncology, Inc.UnusualJun 7, 2018 +199 days
Sold 50,000 shares at $173.54 ($8.7M)
Flaherty Keith T., Director
Sold 83.7% of holdings ($10.4M position)9,732 shares left6.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2018 | Jun 11, 2018 | Loxo Oncology, Inc. | Director | Form 4 sale | 50,000 | $8.7M | 83.7% | Unusual | SEC |
| Nov 20, 2017 | Nov 22, 2017 | Loxo Oncology, Inc. | Director | Form 4 sale | 7,250 | $551k | 42.7% | Unusual | SEC |
| Aug 21, 2017 | Aug 23, 2017 | Loxo Oncology, Inc. | Director | Form 4 sale | 7,250 | $524k | 29.9% | Unusual | SEC |
| May 22, 2017 | May 24, 2017 | Loxo Oncology, Inc. | Director | Form 4 sale | 7,250 | $327k | 23.0% | Plan not stated | SEC |
| Feb 21, 2017 | Feb 23, 2017 | Loxo Oncology, Inc. | Director | Form 4 sale | 7,250 | $301k | 18.7% | Plan not stated | SEC |
| Dec 19, 2016 | Dec 21, 2016 | Loxo Oncology, Inc. | Director | Form 4 sale | 7,250 | $219k | 15.8% | Plan not stated | SEC |
| Sep 7, 2016 | Sep 9, 2016 | Loxo Oncology, Inc. | Director | Form 4 sale | 14,500 | $435k | 24.0% | Plan not stated | SEC |
| Aug 11, 2016 | Aug 12, 2016 | Loxo Oncology, Inc. | Director | Form 4 sale | 15,000 | $390k | 19.9% | Plan not stated | SEC |